Panbela Therapeutics, Inc. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bbdf2120-af43-40d4-8492-f683f45d9927/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-25.6M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-009418 |
| FY 2022 | $-34.1M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-006899 |
| FY 2021 | $-10.0M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-007101 |
| FY 2020 | $-5.8M | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-007154 |
| FY 2019 | $-4.3M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-005968 |
| FY 2018 | $-3.9M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-005461 |
| FY 2017 | $-6.0M | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-005094 |
| FY 2016 | $-5.2M | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-005554 |
| FY 2015 | $-5.4M | 2015-01-01 – 2015-12-31 | evidence 0001437749-16-027017 |
| FY 2014 | $-3.4M | 2014-01-01 – 2014-12-31 | evidence 0001437749-16-027017 |
| FY 2013 | $-194.3k | 2013-01-01 – 2013-12-31 | evidence 0001477932-14-001315 |
| FY 2012 | $282.8k | 2012-01-01 – 2012-12-31 | evidence 0001477932-13-001328 |
| FY 2011 | $-104.5k | 2011-01-01 – 2011-12-31 | evidence 0001477932-13-001328 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Panbela Therapeutics, Inc. — all facts · Revenue · Net Income